OceanFirst Financial Corp. Declares Quarterly Cash Dividend for Series A Preferred Stock

RED BANK, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) — OceanFirst Financial Corp. (NASDAQ:“OCFC”), (the “Company”), announced that its Board of Directors has declared a quarterly cash dividend of $0.4375 per share for every depositary share, representing 1/40th interest in the Series A Preferred Stock, payable on February 17, 2025 to stockholders of record on January 31, 2025.

OceanFirst Financial Corp.’s subsidiary, OceanFirst Bank N.A., founded in 1902, is a regional bank providing financial services throughout New Jersey and in the major metropolitan areas between Massachusetts and Virginia. OceanFirst Bank delivers commercial and residential financing, treasury management, trust and asset management, and deposit services and is one of the largest and oldest community-based financial institutions headquartered in New Jersey. To learn more about OceanFirst, go to www.oceanfirst.com.

Company Contact:

Patrick S. Barrett
Chief Financial Officer
OceanFirst Financial Corp.
Tel: (732) 240-4500, ext. 27507
Email: [email protected]

OceanFirst Financial Corp. Declares Quarterly Cash Dividend for Series A Preferred Stock

Vallourec reduces its carbon footprint by 19% in 4 years

Transaction in Own Shares

Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma

Patrik Hammarén appointed as President of Nokia Technologies

Roche receives FDA clearance with CLIA waiver for cobas® liat molecular tests to diagnose sexually transmitted infections at the point of care

Topics

Vallourec reduces its carbon footprint by 19% in 4 years

Transaction in Own Shares

Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma

Patrik Hammarén appointed as President of Nokia Technologies

Roche receives FDA clearance with CLIA waiver for cobas® liat molecular tests to diagnose sexually transmitted infections at the point of care

Belships ASA: Update on pre-acceptances

Nasdaq Report Identifies Between $25 Billion and $50 Billion in Potential Efficiency Gains in Banks’ Risk and Compliance Functions

Enact Receives Ratings Upgrades from Fitch Ratings

Related Articles

Vallourec reduces its carbon footprint by 19% in 4 years

Transaction in Own Shares

Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma

Patrik Hammarén appointed as President of Nokia Technologies

Roche receives FDA clearance with CLIA waiver for cobas® liat molecular tests to diagnose sexually transmitted infections at the point of care

Company

Headlines

Vallourec reduces its carbon footprint by 19% in 4 years

Transaction in Own Shares

Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma

Patrik Hammarén appointed as President of Nokia Technologies

Newsletter